Tag: Medical Science

Early Academic Pursuits 📚

Assoc. Prof. Dr. Bojan Miletic began his academic journey at the University of Rijeka, Croatia, where he studied medicine from 1986 to 1992. His early education laid a strong foundation for his diverse career in internal medicine, cardiology, and rehabilitation. After completing his medical degree, Dr. Miletic went on to specialize in internal medicine, cardiology, and geriatric rehabilitation through various educational institutions, including the Clinical Hospital Center Rijeka, the Lucerne Cantonal Hospital in Switzerland, and several other renowned centers across Europe. His rigorous training allowed him to acquire multiple certifications and broaden his expertise in interdisciplinary medicine.

Professional Endeavors 🏥

Dr. Miletic has a distinguished professional career, spanning over two decades in various hospitals and rehabilitation centers across Europe. He currently serves as an Associate Professor and Co-Head of the Department of Clinical Medical Sciences at the University of Rijeka, Croatia, where he engages in both student education and clinical research. Alongside his academic duties, he also works as a Specialist in Internal Medicine and Cardiology at Policlinic Primari in Rijeka and the General Hospital and Homeland War Veterans Hospital in Ogulin, Croatia. His work in clinical settings, including the establishment of new medical units, has contributed significantly to the field.

Throughout his career, Dr. Miletic held leadership roles at several prestigious institutions, including the Lucerne Cantonal Hospital in Switzerland, the Zurich Rehabilitation Center, and Herzpark Hardterwald in Germany. His roles ranged from Co-Head of Rehabilitation Centers to Head of Cardiac Rehabilitation Departments. He also contributed to the development of new rehabilitation centers, providing education and training to nurses, physiotherapists, and doctors.

Contributions and Research Focus 🔬

Dr. Miletic has made significant contributions to clinical research, particularly in the areas of geriatric rehabilitation, cardiology, and internal medicine. His work has addressed key health issues such as depression in the elderly, rehabilitation outcomes, and diagnostic challenges in internal medicine. Dr. Miletic’s research has resulted in numerous articles published in respected journals, such as Medicina, J Sport Rehabil, Lancet Oncol, and Int J Cardiol. His studies often focus on innovative treatment methods, diagnostic challenges, and interdisciplinary approaches to medicine, aiming to improve patient outcomes and healthcare practices across various specialties.

Accolades and Recognition 🏅

Dr. Miletic’s contributions to the medical field have not gone unnoticed. He has received several prestigious awards, including the Green Card for contributing to the development of a culture of respect and promotion of patients' rights by the Croatian Movement for the Patients' Rights. He has also been honored by the Croatian Medical Association for his merits in advancing the medical profession and his health and humanitarian efforts. His excellence in clinical research, education, and leadership has earned him recognition from various professional bodies.

Impact and Influence 🌍

With over 20 years of experience in clinical and academic settings, Dr. Miletic has profoundly impacted the fields of cardiology, internal medicine, and rehabilitation. His role in establishing new departments and hospitals has improved medical services and patient care. His international experience and collaborations across Europe have allowed him to influence healthcare practices and medical education in multiple countries. His ongoing participation in congresses, scientific activities, and as a member of numerous professional societies further amplifies his influence on the global medical community.

Legacy and Future Contributions 🔮

Dr. Miletic’s career is marked by his unwavering commitment to improving patient care, advancing medical research, and educating the next generation of healthcare professionals. His work in developing new rehabilitation centers and his leadership in clinical research will continue to shape the future of healthcare in Europe and beyond. As an active member of professional societies like the European Society of Cardiology and the European Society of Cardiovascular Imaging, Dr. Miletic is poised to make continued contributions to the medical field, ensuring that his legacy as a leader in cardiology, rehabilitation, and internal medicine endures for years to come.

Publications

📄Depression and Its Effect on Geriatric Rehabilitation Outcomes in Switzerland’s Aging Population
- - Authors: Bojan Miletic, Antonia Plisic, Lejla Jelovica, Jan Saner, Marcus Hesse, Silvije Segulja, Udo Courteney, Gordana Starcevic-Klasan
  - Journal: Medicina
  - Year: 2025

📄Icterus provoked by Echinococcus mimicking a tumor: A diagnostic challenge
- - Authors: Bojan Miletic, Yves Sutter, Elefteri Buset, Silvije Segulja, Marcus Hesse
  - Journal: Travel Medicine and Infectious Disease
  - Year: 2025

📄The Physical Activity and Dietary Habits of Nursing Students
- Authors: Željko Jovanović, Maja Šarić, Bojan Miletic
- Journal: Medical Research Archives
- Year: 2024

📄Virtual reality in the education of instrumentation techniques for nurses/technicians
- Authors: Marija Spevan, Željko Jovanović, Bojan Miletic
- Journal: World of Health
- Year: 2024

📄Infarkt miokarda s elevacijom ST segmenta kao indikacija za hitan medicinski transport u Opću bolnicu Zadar
- Authors: Slavica Balgavi, Silvije Šegulja, Bojan Miletic
- Event: 27th Congress of Emergency Medicine with International Participation
- Year: 2024

Panupong Hansrivijit | Health Professions | Best Researcher Award

Published on 12/02/202512/02/2025 by Book of Award

Dr. Panupong Hansrivijit | Health Professions | Best Researcher Award

Brigham and Women's Hospital | United States

Author Profile

🌟 Early Academic Pursuits

Dr. Panupong Hansrivijit embarked on his medical journey at Chulalongkorn University, where he graduated with first-class honors in medicine. His passion for internal medicine and nephrology led him to pursue an internship at Thammasat University Hospital, where he gained extensive clinical experience in patient care and medical procedures. This strong academic foundation set the stage for his future endeavors in nephrology research and clinical excellence.

🏥 Professional Endeavors

Dr. Hansrivijit’s medical career took him to the United States, where he completed his Internal Medicine Residency at UPMC Harrisburg. This period was crucial in shaping his skills in patient diagnosis, management, and research methodologies. Currently, he is a Nephrology Fellow at Brigham and Women’s Hospital/Massachusetts General Hospital, specializing in managing complex kidney disorders, dialysis, and transplantation. Simultaneously, he is advancing his expertise in public health through a Master of Public Health (MPH) at Harvard T.H. Chan School of Public Health.

🔬 Contributions and Research Focus

Dr. Hansrivijit has made significant contributions to the field of nephrology, particularly in chronic kidney disease, dialysis, kidney transplantation, and pharmaco-epidemiology. His research spans multiple areas, including machine learning applications in kidney disease prediction, outcomes of kidney transplant recipients, and the impact of metabolic disorders on renal health. His extensive list of publications reflects his dedication to evidence-based medicine and improving patient outcomes.

🏆 Accolades and Recognition

Dr. Hansrivijit's groundbreaking work has earned him multiple prestigious awards, including the Best Researcher Award (2025) from both the International Environmental Awards and the International Invention Awards. His achievements also include multiple Kidney STARS Program Awards from the American Society of Nephrology, a Travel Grant Award from the International Society of Nephrology, and recognition for his contributions to global nephrology research.

🌍 Impact and Influence

Beyond his clinical and research work, Dr. Hansrivijit is an active member of the nephrology community, holding memberships in renowned organizations such as the National Kidney Foundation (NKF) and the American Society of Nephrology (ASN). His contributions in meta-analyses, systematic reviews, and nephrology-based epidemiological research have influenced treatment strategies and policy discussions on kidney disease management worldwide.

🚀 Legacy and Future Contributions

With a growing portfolio of influential research and clinical expertise, Dr. Hansrivijit is set to become a leader in nephrology innovation. His future contributions will likely focus on improving dialysis techniques, optimizing transplant outcomes, and utilizing data-driven methodologies to enhance patient care. His dedication to advancing kidney health and public health policies ensures that his impact will be felt for generations to come.

Publications

📄 Utilization Trends of Glucose-Lowering Medications Among Adult Kidney Transplant Recipients with Type 2 Diabetes in the United States
Author(s): Panupong Hansrivijit, Helen Tesfaye, Deborah J. Wexler, Elisabetta Patorno, Julie M. Paik
Journal: Journal of Clinical Medicine
Year: 2025

📄 A Hospice Transitions Program for Patients in the Emergency Department
Author(s): Christopher William A. Baugh, Kei Ouchi, Jason K. Bowman, Elizabeth M. Rickerson, Mallika Lakshmi Mendu
Journal: JAMA Network Open
Year: 2024

📄 Unpacking Contributors to CKD Incidence and Progression: Time to Move Beyond Traditional Risk Factors
Author(s): Panupong Hansrivijit, Lipika Samal, Mallika Lakshmi Mendu
Journal: American Journal of Kidney Diseases
Year: 2023

📄 Hepatitis E Virus Infection in Hematopoietic Stem Cell Transplant Recipients: A Systematic Review and Meta-Analysis
Author(s): Angkawipa Trongtorsak, Natapat Chaisidhivej, Kritika Yadav, Wisit Cheungpasitporn, Panupong Hansrivijit
Journal: Journal of Investigative Medicine
Year: 2022

📄 Renal Manifestations of Hepatitis E Among Immunocompetent and Solid Organ Transplant Recipients
Author(s): Karthik Reddy Kovvuru, Nicholas Carbajal, Abhinandan Reddy Pakanati, Wisit Cheungpasitporn, Swetha Rani Kanduri
Journal: World Journal of Hepatology
Year: 2022

Dan Liu | Medicine and Dentistry | Best Researcher Award

Published on 20/11/202420/11/2024 by Book of Award

Dr. Dan Liu | Medicine and Dentistry | Best Researcher Award

General Hospital of Ningxia Medical University | China

Author Profile

🌱 Early Academic Pursuits

Dr. Dan Liu began her distinguished journey with a strong foundation in medicine and research. Her academic rigor led her to advanced positions, including her role as a doctoral supervisor and principal investigator. She gained international exposure as a visiting scholar at the University of Iowa and Texas Medical Center, further enhancing her global perspective and expertise in medical sciences.

💼 Professional Endeavors

Currently, Dr. Liu serves as the director of the Ningxia Hysteroscopy Diagnosis and Treatment Center and plays a pivotal role at the General Hospital of Ningxia Medical University. Her leadership in hysteroscopy diagnostics has transformed the medical landscape in Ningxia. Beyond clinical duties, she actively drives innovation and research, influencing medical sciences both regionally and nationally.

🔬 Contributions and Research Focus

Dr. Liu's research portfolio is impressive, including two projects funded by the National Natural Science Foundation of China and one significant national-grade project. She has successfully integrated technological advancements into her field, holding one utility model patent and one invention patent. Her pioneering contributions address critical challenges in women’s health, making significant strides in hysteroscopy techniques and diagnostics.

🏆 Accolades and Recognition

Dr. Liu’s accomplishments have garnered numerous awards, such as the prestigious second prize of the Science and Technology Progress Award of Ningxia Autonomous Region. In 2023, her dedication and exceptional service earned her the "Special Contribution" Award from People’s Daily Online, recognizing her as an excellent doctor. These accolades underscore her impact on medical innovation and patient care.

🌟 Impact and Influence

Through her dual roles in clinical practice and academia, Dr. Liu has shaped the next generation of medical professionals while advancing the field of hysteroscopy. Her leadership in research and treatment has set new benchmarks, directly benefiting patients and fostering a culture of innovation in the medical community.

🔮 Legacy and Future Contributions

As a trailblazer in her field, Dr. Liu’s legacy is one of excellence and commitment to advancing healthcare. Her ongoing projects and visionary leadership promise continued contributions to medical science, inspiring future researchers and clinicians to follow her path of innovation and service.

Publications

📝 Meta-analysis of FOXP3 polymorphisms and recurrent spontaneous abortion susceptibility
Authors: Shuai, R., Li, D., Xu, X., Yang, X., Liu, D.
Journal: American Journal of Reproductive Immunology
Year: 2024

📝 The osteogenesis and the biologic mechanism of thermo-responsive injectable hydrogel containing carboxymethyl chitosan/sodium alginate nanoparticles towards promoting osteal wound healing
Authors: Shi, Z., Yang, F., Pang, Q., Zhu, Y.
Journal: International Journal of Biological Macromolecules
Year: 2023

📝 Bone marrow mesenchymal stem cells combined with estrogen synergistically promote endometrial regeneration and reverse EMT via Wnt/β-catenin signaling pathway
Authors: Yuan, L., Cao, J., Hu, M., Chen, M., Liu, D.
Journal: Reproductive Biology and Endocrinology
Year: 2022

📝 A novel intrauterine barrier for preventing the recurrence of IUA after TCRA procedure
Authors: Chen, M., Yuan, L., Jin, H., Zhang, X., Liu, D.
Journal: Medical Hypotheses
Year: 2022

📝 Organoid Transplantation Can Improve Reproductive Prognosis by Promoting Endometrial Repair in Mice
Authors: Zhang, H., Xu, D., Li, Y., Li, G., Liu, D.
Journal: International Journal of Biological Sciences
Year: 2022

Inmaculada Gilaberte | Medicine and Dentistry | Best Researcher Award

Published on 13/11/202413/11/2024 by Book of Award

Dr. Inmaculada Gilaberte | Medicine and Dentistry | Best Researcher Award

FAES Farma | Spain

Author Profile

🌱 Early Academic Pursuits

Dr. Inmaculada Gilaberte’s academic journey is rooted in a commitment to excellence and medical advancement. She initially pursued education in clinical research, equipping herself with in-depth knowledge and skills in therapeutic areas such as neuroscience and immunology. Her academic foundation was further strengthened by certifications, including a lecturer certification from the Spanish Quality Register Agency (ANECA), and advanced leadership programs from institutions like Stanford and MIT. These formative experiences shaped her growth mindset, laying the groundwork for a career dedicated to precision, patient-centered care, and effective team collaboration.

💼 Professional Endeavors

Throughout her career, Dr. Gilaberte has held prominent roles in major pharmaceutical companies such as FAES FARMA, Takeda, TiGenix, Roche, and Lilly, with positions spanning from Clinical Research Physician to Director of Clinical Research. She has led various departments, managed global teams, and directed clinical trials across multiple therapeutic areas, including gastroenterology, immunology, cardiology, and pain management. Her strategic guidance has driven several landmark projects forward, including the advancement of microbiome and cell therapies from preclinical to first-in-human trials, demonstrating her expertise in transforming innovative therapies into viable treatment options.

🧬 Contributions and Research Focus

Dr. Gilaberte has made notable contributions to clinical research, particularly in stem cell therapy, immunology, and neuroscience. Her pioneering work on Darvadstrocel, an allogeneic adipose-derived mesenchymal stem cell therapy, led to significant strides in treating perianal fistulas and positioned her as a leader in regenerative medicine. She has been instrumental in launching global clinical trials, developing target product profiles (TPP), and submitting regulatory applications for FDA and EMA approvals. With a robust publication record, including 66 papers indexed in PubMed, she continues to contribute to scientific literature, sharing her findings and advancing the field of biomedicine.

🏆 Accolades and Recognition

Dr. Gilaberte’s excellence has been recognized through numerous awards across her roles in clinical development and leadership. Her achievements include multiple awards for her work in the clinical progression of innovative therapies and successful drug submissions to global regulatory bodies. She has received recognition for her strategic contributions to the Darvadstrocel trials and for advancing neuroscience programs in Alzheimer’s disease. Her leadership has earned her high regard in the industry, with acknowledgments from institutions and colleagues alike.

🌍 Impact and Influence

Dr. Gilaberte’s impact extends beyond her immediate professional roles. Her contributions to clinical science have enhanced treatment options for patients with complex diseases, and her leadership has shaped clinical strategies in multinational pharmaceutical companies. She has also promoted effective collaboration across global, cross-functional teams, fostering a diverse and inclusive work environment that prioritizes patient needs. Her initiatives in regulatory compliance, risk management, and data integration have set new standards for clinical operations, solidifying her influence as a thought leader in her field.

📜 Legacy and Future Contributions

Looking ahead, Dr. Gilaberte’s legacy is one of commitment to advancing patient care through innovation, collaboration, and strategic foresight. Her future endeavors are poised to make an enduring impact, with ongoing research and leadership contributions that will shape the future of clinical development. Her philanthropic work, such as building a nursery in Uganda, highlights her dedication to global well-being beyond her professional achievements. Dr. Gilaberte continues to inspire the next generation of clinical researchers, ensuring that her legacy of precision, empathy, and patient-first innovation will endure.

Publications

📄 Efficacy and Safety of Weekly Calcifediol Formulations (75 and 100 µg) in Subjects with Vitamin D Deficiency: A Phase II/III Randomised Trial

Authors: Esteban Jódar-Gimeno, Jose Luis Pérez-Castrillón, Ján Nociar, Michal Lojka, Dimitar Nikolov, Fernando Cereto-Castro, Snežana Novković, Umberto Tarantino, Nadia Mehsen-Cetre, Paula Arranz, Cristina Martínez Ostalé, Aintzane García-Bea, Inmaculada Gilaberte
Journal: Nutrients
Year: 2024

📄 Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial

Authors: Coimbra, J., Puntes, M., Molina, P., Arranz, P., Sánchez, C.
Journal: European Journal of Pharmaceutical Sciences
Year: 2024

📄 Bioequivalence and Safety of Bilastine 20 mg Orodispersible Tablets and Conventional Tablets: A Randomized, Single-Dose, Two-Period Crossover Study in Healthy Volunteers Under Fasting Conditions

Authors: Román, M., Ochoa, D., Martin, S., Arranz, P., Sánchez, C.
Journal: Drugs in R and D
Year: 2024

📄 Disease Burden, Treatment Patterns, and Economic Impact of Rectovaginal Fistulas in Patients with Crohn’s Disease: Findings from a Retrospective, Observational, Longitudinal Study Based on US Claims Databases

Authors: Karki, C., Latremouille-Viau, D., Gilaberte, I., Romdhani, H., Lightner, A.L.
Journal: PharmacoEconomics
Year: 2023

📄 Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn’s Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial

Authors: Garcia-Olmo, D., Gilaberte, I., Binek, M., Spinelli, A., Panés, J.
Journal: Diseases of the Colon and Rectum
Year: 2022

Shadi Hamoud | Medicine and Dentistry | Best Researcher Award

Published on 18/10/202418/10/2024 by Book of Award

Assist Prof Dr. Shadi Hamoud | Medicine and Dentistry | Best Researcher Award

Rambam Health Care Campus | Israel

Author Profile

Early Academic Pursuits 🎓

Dr. Shadi Hamoud's academic journey began with the completion of his MD (cum laude) from the Faculty of Medicine at the Hebrew University, Jerusalem, in 1995. His commitment to medical excellence was evident from the beginning, as he specialized in Internal Medicine during his residency at Rambam Medical Center from 1996 to 2002. His passion for teaching also emerged early, as he served as a tutor and lecturer for medical students and advanced nursing courses at Rambam Health Care Campus.

Professional Endeavors 🏥

Dr. Hamoud has held several key roles throughout his career. Since 2010, he has been the Director of the Clinical Research Unit at the Internal Medicine E Department, Rambam Medical Center. He also serves as the Deputy Director of the same department. His expertise is sought by major pharmaceutical companies such as Bayer and Pfizer, where he has been a medical consultant since 2016 and 2017, respectively. Additionally, Dr. Hamoud plays a vital role on various medical committees, including the committee for blood product transfusions at Rambam and the specialty committee within the hospital.

Contributions and Research Focus 🔬

Dr. Hamoud's research interests are broad, focusing on critical issues in cardiovascular medicine, diabetes, and novel COVID-19 treatments. He has investigated lipoprotein oxidation and atherosclerosis, as well as the enzyme heparanase and its impact on kidney injuries, fatty liver disease, and other conditions. His involvement in international clinical trials and research on lipid-modifying drugs and new oral anticoagulants highlights his commitment to advancing medical science.

Accolades and Recognition 🏅

Dr. Hamoud has received numerous awards throughout his career, recognizing his dedication to both medicine and education. Between 2003 and 2016, he was named an Excellent Lecturer by the Internal Medicine E Department at Rambam Health Care Campus. In 2008, he was also honored with an Excellence in Medicine award, further cementing his reputation as a distinguished medical professional.

Impact and Influence 🌍

Dr. Hamoud’s influence extends beyond academia and clinical practice. He has been actively involved in public health education, delivering lectures at local schools in his hometown of Majd Al-Kurum. His role as an examiner in Israel’s internal medicine specialization exams underscores his commitment to shaping the next generation of medical professionals. He has also contributed to the medical field through his membership in professional societies, including the European Society of Hypertension and the Israeli Society of Hypertension.

Legacy and Future Contributions 🌱

Dr. Hamoud's work in medical research, clinical practice, and education has left a lasting impact on the healthcare field in Israel and beyond. His ongoing roles in clinical research, his contributions to new therapies for chronic diseases, and his mentorship of future doctors ensure that his influence will continue to grow. As a leader in both medicine and research, his legacy is one of commitment to improving health outcomes and advancing scientific knowledge for the benefit of future generations

Publications

📄"Gender-Specific Renoprotective Pathways in αMUPA Transgenic Mice Subjected to Acute Kidney Injury" 🐭
Authors: Heba Abd Alkhaleq, Shadi Hamoud, Israel Hacker, Tony Karram, Ahmad Fokra, Aviva Kabala, Zaid Abassi
Journal: International Journal of Molecular Sciences
Year: 2024

📄"Effects of Angiotensin 1-7 and Mas Receptor Agonist on Renal System in a Rat Model of Heart Failure" 🐀
Authors: Ravit Cohen-Segev, Omri Nativ, Safa Kinaneh, Doron Aronson, Aviva Kabala, Shadi Hamoud, Tony Karram, Zaid Abassi
Journal: International Journal of Molecular Sciences
Year: 2023

📄"Heparanase Inhibition Prevents Liver Steatosis in E₀ Mice" 🧬
Authors: Safa Kinaneh, Walaa Hijaze, Lana Mansour-Wattad, Rawan Hammoud, Hisam Zaidani, Aviva Kabala, Shadi Hamoud
Journal: Journal of Clinical Medicine
Year: 2022

Theodoros Grivas | Medicine and Dentistry | Lifetime Achievement Award

Published on 28/08/202428/08/2024 by Book of Award

Dr. Theodoros Grivas | Medicine and Dentistry | Lifetime Achievement Award

Tzaneio General Hospital of Piraeus | Greece

Aurhor Profile

🎓 Early Academic Pursuits

Dr. Theodoros B. Grivas began his illustrious journey in medicine by graduating from the Medical School at “Aristotle” University of Thessaloniki in 1978. His academic foundation was further solidified through comprehensive training in General Surgery, Paediatric and Adult Orthopaedics, and Traumatology in Greece. Driven by a passion for deepening his expertise, he pursued and earned a Ph.D. from the National and Kapodistrian University of Athens, establishing a robust foundation for his future contributions to orthopaedic and spinal surgery.

💼 Professional Endeavors

Throughout his career, Dr. Grivas worked at prestigious institutions, including the “University Hospital” at Queen’s Medical Centre in Nottingham, “Harlow Wood” Orthopaedic Hospital in Mansfield, UK, and prominent hospitals in Athens, Greece. Notably, he served as the Director of the Orthopaedics and Traumatology Department at “Thriasio” Hospital for five years and later at “Tzaneio” General Hospital of Piraeus for 12 years until his retirement in 2021. His leadership and expertise significantly impacted the field, where he played a pivotal role in advancing patient care and surgical practices.

🔬 Contributions and Research Focus

Dr. Grivas has an impressive record of scientific contributions, including over 645 scientific publications and presentations, with 136 indexed in Medline. His research spans various orthopaedic and spinal topics, with a particular focus on school screening programs and spinal deformities. As a principal investigator or collaborator, he was involved in 20 research projects, funded by national and European sources. Additionally, he established a National Training Center for school-screening examiners and was a key figure in implementing the School Screening program in Greece.

🏆 Accolades and Recognition

Dr. Grivas’s achievements have been recognized both nationally and internationally. He has served as a member and Traveling Fellow of renowned organizations like AAOS, AOA, and SRS. He held the presidency of the IRSSD, SOSORT (which he helped found), and the Hellenic Spine Society. His editorial contributions include serving as the Chief Editor of the BMC open access journal “Scoliosis and Spinal Deformities,” and as a member of the editorial board or a reviewer for several peer-reviewed journals. His department was also honored with the opportunity to provide the “Trialect platform” Fellowship in Orthopaedics and Traumatology.

🌍 Impact and Influence

Dr. Grivas’s influence extends beyond his immediate clinical work, impacting the broader medical community through his involvement in critical decision-making bodies. During 2019-2020, he served on the National Examination Committee for Orthopaedics and Traumatology and was a member of the Crisis and Selection Council of the Hellenic National Health System from 2020-2021, which is responsible for the appointment of Orthopaedic Surgeons in State Hospital Positions.

🚀 Legacy and Future Contributions

Even in retirement, Dr. Grivas continues to contribute to the field he has dedicated his life to. He is currently focused on establishing the Hellenic Scoliosis Foundation, aiming to further advance the understanding and treatment of scoliosis. His enduring legacy lies in his vast body of work, the numerous professionals he has mentored, and the patients whose lives he has improved through his expertise in orthopaedics and spinal surgery. His future contributions promise to leave a lasting impact on the field, continuing to inspire and guide the next generation of surgeons.

Publications

📄 Rib index is a strong surrogate of scoliometric reading in idiopathic scoliosis
Author(s): Grivas, T.B., Jevtic, N., Ljubojevic, D., Mamzari, A., Vasiliadis, E.
Journal: European Spine Journal
Year: 2024

📄 Cross-cultural adaptation, reliability and validity of the Greek version of the Spinal Appearance Questionnaire (SAQ) in patients with adolescent idiopathic scoliosis
Author(s): Oikonomaki, M., Kelalis, G., Skouras, A.Z., Georgoudis, G., Grivas, T.
Journal: Spine Deformity
Year: 2024

📄 A Questionnaire of Physiotherapeutic Specific Exercises of Scoliosis—QPSSE
Author(s): Grivas, T.B., Dadakaridou, D., Fokidi, S.A., Theodosopoulos, E., Griva, A.M.
Journal: Journal of Clinical Medicine
Year: 2024

📄 Menarche in Scoliotic and Non-Scoliotic Balkan Girls and the Relationship between Menarche and the Laterality of Scoliotic Curves
Author(s): Pjanic, S., Jevtic, N., Grivas, T.B.
Journal: Journal of Clinical Medicine
Year: 2024

📄 Segmental Rib Index and Spinal Deformity: Scoliogenic Implications
Author(s): Grivas, T.B., Jevtic, N., Ljubojevic, D., Golic, F., Vasiliadis, E.
Journal: Healthcare (Switzerland)
Year: 2023

Jiang hua Yang | Medicine and Dentistry | Best Researcher Award

Published on 19/07/202420/07/2024 by Book of Award

Dr. Jianghua Yang | Medicine and Dentistry | Best Researcher Award

Yijishan Hospital | China

Author Profile

Early Academic Pursuits

Dr. Jianghua Yang began his academic journey in the medical field with a focus on infectious diseases. His foundational studies laid the groundwork for a career dedicated to understanding and combating a variety of infectious diseases. Over the years, Dr. Yang has honed his expertise and developed a deep research interest in several key areas, including tuberculosis, severe fever with thrombocytopenia syndrome, schistosomiasis, and hepatitis.

Professional Endeavors

Dr. Jianghua Yang is currently associated with the Department of Infectious Diseases at Yijishan Hospital of Wannan Medical College in Wuhu, Anhui, China. In his professional role, he has undertaken significant research projects and contributed extensively to the field of infectious diseases. His work is characterized by a commitment to advancing medical knowledge and improving patient outcomes through rigorous scientific inquiry and collaboration with other researchers.

Contributions and Research Focus

Dr. Yang's research spans several critical areas in infectious diseases. His studies on tuberculosis have been published in reputable journals such as "Tuberculosis (Edinb)" and the "International Journal of Infectious Diseases". His work on severe fever with thrombocytopenia syndrome has appeared in the "Journal of Medical Virology" and the "Japanese Journal of Infectious Diseases". Additionally, Dr. Yang has investigated schistosomiasis, with his findings published in "Scientific Reports" and "Journal of Cancer". His research on hepatitis has been featured in the "European Journal of Gastroenterology & Hepatology" and "BMC Gastroenterology". These contributions have not only enhanced the understanding of these diseases but have also provided valuable insights into their diagnosis, treatment, and management.

Accolades and Recognition

Throughout his career, Dr. Yang has received recognition for his impactful research and contributions to the field of infectious diseases. His publications have been cited by peers, reflecting the significance and influence of his work. Dr. Yang's dedication to advancing medical science has earned him respect and acknowledgment within the academic and medical communities.

Impact and Influence

Dr. Yang's research has had a substantial impact on the understanding and treatment of infectious diseases. His work on tuberculosis and severe fever with thrombocytopenia syndrome has informed clinical practices and guided further research in these areas. By elucidating the complexities of diseases such as schistosomiasis and hepatitis, Dr. Yang has contributed to the development of more effective diagnostic and therapeutic strategies, thereby improving patient care and outcomes.

Legacy and Future Contributions

Dr. Jianghua Yang's legacy in the field of infectious diseases is marked by his significant research contributions and his commitment to advancing medical knowledge. As he continues his work, Dr. Yang is poised to make further groundbreaking discoveries that will enhance the understanding of infectious diseases and lead to better health outcomes worldwide. His ongoing research and dedication to scientific excellence will undoubtedly inspire future generations of researchers and healthcare professionals.

Notable Publications

Construction of an early differentiation diagnosis model for patients with severe fever with thrombocytopenia syndrome and hemorrhagic fever with renal syndrome 2024

Prevalence and impact of viral myocarditis in patients with severe fever with thrombocytopenia syndrome 2024

Clinicopathological characteristics and its association with digestive system tumors of 1111 patients with Schistosomiasis japonica 2023 (1)

A risk prediction model for acute kidney injury in patients with pulmonary tuberculosis during anti-tuberculosis treatment 2022 (4)

Ao Gu | Medicine and Dentistry | Best Researcher Award

Published on 22/02/202422/02/2024 by Book of Award

Dr. Ao Gu | Medicine and Dentistry | Best Researcher Award

Shanghai Jiao Tong University School of Medicine | China

Author profile

Six-Membered Aromatic Nitrogen Heterocyclic Anti-Tumor Agents: Synthesis and Applications 2023

Early Academic Pursuits

Dr. Ao Gu completed his M.B in Clinical Medicine at Hebei University Health Science Center and is pursuing a master's degree at Shanghai Jiao Tong University School of Medicine, focusing on antitumor-active molecules under Prof. Yingbin Liu's mentorship.

Professional Endeavors

With a background in Clinical Medicine, Dr. Gu's professional journey includes extensive research in therapeutic molecules. He actively contributes to the scientific community through his publications and ongoing academic pursuits.

Contributions and Research Focus

Dr. Gu's research primarily centers on exploring the therapeutic capabilities of antitumor-active molecules. His work spans various aspects of medicine and chemistry, ranging from patient-derived models to single-cell omics analysis.

Accolades and Recognition

Dr. Ao Gu has gained recognition for his significant contributions to the field, as evidenced by his publications in reputable scientific journals. His work has been acknowledged for its innovation and potential impact on cancer research.

Impact and Influence

Through his research, Dr. Gu has the potential to influence advancements in cancer treatment and therapeutic molecule development. His contributions add valuable insights to the scientific community's understanding of antitumor agents.

Legacy and Future Contributions

Dr. Ao Gu's legacy lies in his dedication to advancing medical knowledge and developing novel therapeutic approaches. His future contributions are anticipated to further enrich the field of oncology and inspire aspiring researchers in the pursuit of medical excellence.

Notable Publications

Aggregation-enabled alkene insertion into carbon–halogen bonds 2023 (1)

Solvent-free and Catalyst-free Direct Alkylation of Alkenes 2023 (1)

Trisubstituted alkenes featuring aryl groups: stereoselective synthetic strategies and applications 2023 (3)

Jyoti Upadhyay | Health Professions | Women Research Award

Published on 16/02/202416/02/2024 by Book of Award

Dr. Jyoti Upadhyay | Health Professions | Women Research Award

School of Health Sciences and Technology UPES | India

Author Profile